But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...

U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...

FDA's Embrace of AI to Speed Up Drug Approvals Leaves Industry Observers Excited, Uneasy 6 minute read June 06, 2025. By. ... Already, they can seek expedited approval pathways, ...